COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1881: Articles 18801-18810  | Next

SARS-CoV-2 spike protein arrested in the closed state induces potent neutralizing responses
Carnell, G. W., Ciazynska, K. A., Wells, D. A., Xiong, X., Aguinam, E. T., McLaughlin, S. H., Mallery, D., Ebrahimi, S., Ceron-Gutierrez, L., James, L. C., Doffinger, R., Heeney, J. L., Briggs, J. A. G.
10.1101/2021.01.14.426695 — Posted: 2021-01-14
Mutation rates and selection on synonymous mutations in SARS-CoV-2
De Maio, N., Walker, C. R., Turakhia, Y., Lanfear, R., Corbett-Detig, R., Goldman, N.
10.1101/2021.01.14.426705 — Posted: 2021-01-14
Impacts of 203/204: RG>KR mutation in the N protein of SARS-CoV-2
Vahed, M., Calcagno, T. M., Quinonez, E., Mirsaeidi, M.
10.1101/2021.01.14.426726 — Posted: 2021-01-14
Anti-CoVid19 plasmid DNA vaccine induces a potent immune response in rodents by Pyro-drive Jet Injector intradermal inoculation
Nishikawa, T., Chang, C. Y., Tai, J. A., Hayashi, H., Sun, J., Torii, S., Ono, C., Matsuura, Y., Ide, R., Mineno, J., Sasai, M., Yamamoto, M., Nakagami, H., Yamashita, K.
10.1101/2021.01.13.426436 — Posted: 2021-01-14
Surveillance of genetic diversity and evolution in locally transmitted SARS-CoV-2 in Pakistan during the first wave of the COVID-19 pandemic
Shakeel, M., Irfan, M., Nisa, Z., Rashid, M., Ansari, S. K., Khan, I. A.
10.1101/2021.01.13.426548 — Posted: 2021-01-14
The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.
Calcagnile, M., Forgez, P., Alifano, P., Alifano, M.
10.1101/2021.01.12.426365 — Posted: 2021-01-14
Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2
Palmer, M. V., Martins, M., Falkenberg, S., Buckley, A. C., Caserta, L. C., Mitchell, P. K., Cassmann, E., Rollins, A., Zylich, N. C., Renshaw, R. W., Guarino, C., Wagner, B., Lager, K., Diel, D. G.
10.1101/2021.01.13.426628 — Posted: 2021-01-14 Discussion: Offsite
A highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative elicits high titers of neutralizing antibodies
Malladi, S. K., Patel, U. R., Singh, R., Pandey, S., Kumar, S., Gayathri, S., Kalita, P., Pramanick, I., Reddy, P., Girish, N., Upadhyaya, A., Khan, M. S., Bhat, M., Mani, S., Bhattacharyya, S., Siddiqui, S., Tyagi, A., Jha, S., Pandey, R., Dutta, S., Ringe, R. P., Varadarajan, R.
10.1101/2021.01.13.426626 — Posted: 2021-01-14
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
McCallum, M., De Marco, A., Lempp, F., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., Zepeda, S., di Iulio, J., Bowen, J. E., Montiel-Ruiz, M., Zhou, J., Rosen, L., Bianchi, S., Guarino, B., Silacci Fregni, C., Abdelnabi, R., Foo, S.-Y. C., Rothlauf, P. W., Bloyet, L.-M., Benigni, F., Cameroni, E., Neyts, J., Riva, A., Snell, G., Telenti, A., Whelan, S. P., Virgin, H. W., Corti, D., Pizzuto, M. S., Veesler, D.
10.1101/2021.01.14.426475 — Posted: 2021-01-14 Discussion: Onsite
Occupational and environmental exposure to SARS-CoV-2 in and around infected mink farms
de Rooij, M. M. T., Hakze-Van der Honing, R., Hulst, M., Harders, F., Engelsma, M., van de Hoef, W., Meliefste, K., Nieuwenweg, S., Oude Munnink, B., van Schothorst, I., Sikkema, R., van der Spek, A., Spierenburg, M., Spithoven, J., Bouwstra, R., Molenaar, R.-J., Koopmans, M., Stegeman, A., Van der Poel, W. H. M., Smit, L. A. M.
10.1101/2021.01.06.20248760 — Posted: 2021-01-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).